Ginkgo Bioworks Holdings Inc (NYSE: DNA) kicked off on Monday, down -7.17% from the previous trading day, before settling in for the closing price of $9.34. Over the past 52 weeks, DNA has traded in a range of $5.00-$17.58.
Healthcare Sector giant saw their annual sales slid by -27.97% over the last five years. While this was happening, its average annual earnings per share was recorded 46.44%. With a float of $42.40 million, this company’s outstanding shares have now reached $45.32 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ginkgo Bioworks Holdings Inc is 26.37%, while institutional ownership is 55.21%. The most recent insider transaction that took place on Dec 15 ’25, was worth 6,540. Before that another transaction happened on Dec 10 ’25, when Company’s Officer proposed sale 2,200 for $9.54, making the entire transaction worth $20,988.
Ginkgo Bioworks Holdings Inc (DNA) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.21 earnings per share (EPS), higher than consensus estimate (set at -1.3) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.90% during the next five years compared to -27.97% drop over the previous five years of trading.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators
Take a look at Ginkgo Bioworks Holdings Inc’s (DNA) current performance indicators. Last quarter, stock had a quick ratio of 4.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.23, a number that is poised to hit -1.46 in the next quarter and is forecasted to reach -4.47 in one year’s time.
Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)
Analysing the last 5-days average volume posted by the [Ginkgo Bioworks Holdings Inc, DNA], we can find that recorded value of 0.99 million was lower than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 48.22%.
During the past 100 days, Ginkgo Bioworks Holdings Inc’s (DNA) raw stochastic average was set at 12.82%, which indicates a significant decrease from 15.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.58 in the past 14 days, which was lower than the 0.94 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.00, while its 200-day Moving Average is $9.97. Now, the first resistance to watch is $9.15. This is followed by the second major resistance level at $9.62. The third major resistance level sits at $9.88. If the price goes on to break the first support level at $8.42, it is likely to go to the next support level at $8.16. Should the price break the second support level, the third support level stands at $7.69.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Key Stats
The company with the Market Capitalisation of 525.32 million has total of 60,590K Shares Outstanding. Its annual sales at the moment are 227,040 K in contrast with the sum of -547,030 K annual income. Company’s last quarter sales were recorded 38,840 K and last quarter income was -80,760 K.
